GMO Emerging Country Debt Fund

GMO Emerging Country Debt Fund

GMCDX
GMO Emerging Country Debt FundUS flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
GMO Emerging Country Debt Fund (GMCDX) is an open-end mutual fund that seeks total return in excess of the J.P. Morgan Emerging Markets Bond Index Global Diversified (EMBI-GD) through a bottom-up investment approach focused on external debt of emerging country sovereigns and quasi-sovereigns, typically denominated in U.S. dollars, euros, Japanese yen, Swiss francs, or British pounds sterling; the fund invests directly and indirectly at least 80% of its assets in such debt securities, employing derivatives including swaps, futures, forwards, options, and reverse repurchase agreements for risk management, hedging, and enhanced returns. Core holdings emphasize government bonds, corporate bonds from emerging issuers, government-related debt, and cash equivalents, with top positions including Mexican sovereign bonds, Petroleos Mexicanos notes, and interest rate swaps; diversification spans non-U.S. bonds (81%), U.S. stocks (12%), cash (3%), and U.S. bonds (3%), targeting primarily institutional investors with a minimum initial investment of $1 million. Launched on April 19, 1994, and domiciled in the United States as a series of GMO Trust, the fund is managed by GMO LLC (Grantham, Mayo, Van Otterloo & Co. LLC), headquartered in Boston with additional offices in San Francisco, London, Amsterdam, Singapore, Sydney, and Tokyo. The fund's Emerging Country Debt team, led by Portfolio Manager Tina Vandersteel since October 1, 2015, employs fundamental analysis emphasizing default characteristics and cash flows over macroeconomic forecasting to select undervalued issues outperforming the benchmark's risk profile; as of late 2025, total net assets stand at approximately $2.44 billion, with Class III share class size at $818 million, a net expense ratio of 0.61%, front-end load of 0.75%, and maximum redemption fee of 0.75%; geographic focus covers emerging markets globally, with significant exposure to issuers in Mexico, South Africa, Poland, Oman, Dominican Republic, and others via high-yield fixed income instruments rated Baa3/BBB- or below. Recent developments include GMO's July 2025 reiteration of its "once-in-a-generation" opportunity call on emerging market local currency debt—initially made in January 2024—which has delivered over 10% returns amid favorable post-pandemic credit spreads and U.S. policy tailwinds under President Donald Trump, though the hard-currency focused GMCDX has similarly benefited from resilient EM debt performance; in September 2024, GMO published research advocating permanent allocations to EM debt due to overcompensating credit spreads versus actual losses, contrasting it with U.S. high-yield shifts to private markets; the semi-annual report as of August 31, 2025, confirmed ongoing portfolio adjustments amid stable management and benchmark adherence, with no reported acquisitions, partnerships, funding rounds, or reorganizations specific to the fund in the last 1-2 years.